Home › Cholesterol › California › San Francisco
Cholesterol clinical trials in San Francisco, CA
3 studies for Cholesterol are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Sutter Health Heart and Vascular, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
RecruitingPhase 3
- UC San Francisco Medical Center, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC7 studies
- Hialeah, FL6 studies
- Jacksonville, FL5 studies
- Richmond, VA4 studies
- Houston, TX4 studies
- Deltona, FL4 studies
- St. Louis, MO3 studies
- Salt Lake City, UT3 studies
- Anderson, SC3 studies
- Chicago, IL3 studies
- Winston-Salem, NC3 studies
- Wichita, KS3 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.